A Novel cVAE-Augmented Deep Learning Framework for Pan-Cancer RNA-Seq Classification
- URL: http://arxiv.org/abs/2508.02743v1
- Date: Sat, 02 Aug 2025 16:57:31 GMT
- Title: A Novel cVAE-Augmented Deep Learning Framework for Pan-Cancer RNA-Seq Classification
- Abstract summary: We propose a novel deep learning framework that uses a class-conditional variational autoencoder (cVAE) to augment training data for pan-cancer gene expression classification.<n>We present detailed experimental results, including VAE training curves, performance metrics (ROC curves and confusion matrix), and architecture diagrams.
- Score: 0.0
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Pan-cancer classification using transcriptomic (RNA-Seq) data can inform tumor subtyping and therapy selection, but is challenging due to extremely high dimensionality and limited sample sizes. In this study, we propose a novel deep learning framework that uses a class-conditional variational autoencoder (cVAE) to augment training data for pan-cancer gene expression classification. Using 801 tumor RNA-Seq samples spanning 5 cancer types from The Cancer Genome Atlas (TCGA), we first perform feature selection to reduce 20,531 gene expression features to the 500 most variably expressed genes. A cVAE is then trained on this data to learn a latent representation of gene expression conditioned on cancer type, enabling the generation of synthetic gene expression samples for each tumor class. We augment the training set with these cVAE-generated samples (doubling the dataset size) to mitigate overfitting and class imbalance. A two-layer multilayer perceptron (MLP) classifier is subsequently trained on the augmented dataset to predict tumor type. The augmented framework achieves high classification accuracy (~98%) on a held-out test set, substantially outperforming a classifier trained on the original data alone. We present detailed experimental results, including VAE training curves, classifier performance metrics (ROC curves and confusion matrix), and architecture diagrams to illustrate the approach. The results demonstrate that cVAE-based synthetic augmentation can significantly improve pan-cancer prediction performance, especially for underrepresented cancer classes.
Related papers
- Interpretable Graph Kolmogorov-Arnold Networks for Multi-Cancer Classification and Biomarker Identification using Multi-Omics Data [36.92842246372894]
Multi-Omics Graph Kolmogorov-Arnold Network (MOGKAN) is a deep learning framework that utilizes messenger-RNA, micro-RNA sequences, and DNA methylation samples.<n>By integrating multi-omics data with graph-based deep learning, our proposed approach demonstrates robust predictive performance and interpretability.
arXiv Detail & Related papers (2025-03-29T02:14:05Z) - scMamba: A Pre-Trained Model for Single-Nucleus RNA Sequencing Analysis in Neurodegenerative Disorders [43.24785083027205]
scMamba is a pre-trained model designed to improve the quality and utility of snRNA-seq analysis.<n>Inspired by the recent Mamba model, scMamba introduces a novel architecture that incorporates a linear adapter layer, gene embeddings, and bidirectional Mamba blocks.<n>We demonstrate that scMamba outperforms benchmark methods in various downstream tasks, including cell type annotation, doublet detection, imputation, and the identification of differentially expressed genes.
arXiv Detail & Related papers (2025-02-12T11:48:22Z) - LASSO-MOGAT: A Multi-Omics Graph Attention Framework for Cancer Classification [41.94295877935867]
This paper introduces LASSO-MOGAT, a graph-based deep learning framework that integrates messenger RNA, microRNA, and DNA methylation data to classify 31 cancer types.
arXiv Detail & Related papers (2024-08-30T16:26:04Z) - Towards a Benchmark for Colorectal Cancer Segmentation in Endorectal Ultrasound Videos: Dataset and Model Development [59.74920439478643]
In this paper, we collect and annotated the first benchmark dataset that covers diverse ERUS scenarios.
Our ERUS-10K dataset comprises 77 videos and 10,000 high-resolution annotated frames.
We introduce a benchmark model for colorectal cancer segmentation, named the Adaptive Sparse-context TRansformer (ASTR)
arXiv Detail & Related papers (2024-08-19T15:04:42Z) - Pan-cancer gene set discovery via scRNA-seq for optimal deep learning based downstream tasks [6.869831177092736]
We analyzed scRNA-seq data from 181 tumor biopsies across 13 cancer types.
High-dimensional weighted gene co-expression network analysis (hdWGCNA) was performed to identify relevant gene sets.
Oncogenes from OncoKB evaluated with deep learning models, including multilayer perceptrons (MLPs) and graph neural networks (GNNs)
arXiv Detail & Related papers (2024-08-13T23:24:36Z) - OMG-Net: A Deep Learning Framework Deploying Segment Anything to Detect Pan-Cancer Mitotic Figures from Haematoxylin and Eosin-Stained Slides [27.84599956781646]
In this study, we propose an artificial intelligence (AI) approach to detect MFs in digitised whole slide images (WSIs)
Here we establish the largest pan-cancer dataset of mitotic figures by combining an in-house dataset of soft tissue tumours (STMF) with five open-source mitotic datasets (IPAC, TUPAC, CCMCT, CMC and MIDOG++)
We then employed a two-stage framework (Optimised Mitoses Generator Network (OMG-Net)) classify MFs.
arXiv Detail & Related papers (2024-07-17T17:53:37Z) - Contrastive Learning for Predicting Cancer Prognosis Using Gene Expression Values [3.1298840947078372]
We train a classifier to categorize tumors into a high- or low-risk group of recurrence.
Our CL-based classifiers achieved an area under the receiver operating characteristic curve (AUC) greater than 0.8 for 14 types of cancer.
Our CLCox models trained with the TCGA data outperformed existing methods significantly in predicting the prognosis of 19 types of cancer.
arXiv Detail & Related papers (2023-06-09T22:03:18Z) - Machine Learning Methods for Cancer Classification Using Gene Expression
Data: A Review [77.34726150561087]
Cancer is the second major cause of death after cardiovascular diseases.
Gene expression can play a fundamental role in the early detection of cancer.
This study reviews recent progress in gene expression analysis for cancer classification using machine learning methods.
arXiv Detail & Related papers (2023-01-28T15:03:03Z) - Improving Precancerous Case Characterization via Transformer-based
Ensemble Learning [31.891340667123124]
The application of natural language processing to cancer pathology reports has been focused on detecting cancer cases.
Improving the characterization of precancerous adenomas assists in developing diagnostic tests for early cancer detection and prevention.
Our results demonstrated the potential of using NLP to leverage real-world health record data to facilitate the development of diagnostic tests for early cancer prevention.
arXiv Detail & Related papers (2022-12-10T00:06:28Z) - Gene selection from microarray expression data: A Multi-objective PSO
with adaptive K-nearest neighborhood [0.0]
This paper deals with the classification problem of human cancer diseases by using gene expression data.
It is presented a new methodology to analyze microarray datasets and efficiently classify cancer diseases.
arXiv Detail & Related papers (2022-05-27T04:22:10Z) - Deep Learning Based Model for Breast Cancer Subtype Classification [3.419451872918847]
This paper focuses on the use of gene expression data for the classification of breast cancer into four subtypes, Basal, Her2, LumA, and LumB.
The size of the feature set is reduced from 20,530 gene expression values to 500 by using an autoencoder.
By deploying the combined network of stages 1 and 2, we have been able to attain a mean 10-fold test accuracy of 0.907 on the TCGA breast cancer dataset.
arXiv Detail & Related papers (2021-11-06T17:15:35Z) - DeepGene Transformer: Transformer for the gene expression-based classification of cancer subtypes [5.179504118679301]
Cancer and its subtypes constitute approximately 30% of all causes of death globally.
DeepGene Transformer is proposed which addresses the complexity of high-dimensional gene expression with a multi-head self-attention module.
arXiv Detail & Related papers (2021-08-26T15:02:55Z) - Topological Data Analysis of copy number alterations in cancer [70.85487611525896]
We explore the potential to capture information contained in cancer genomic information using a novel topology-based approach.
We find that this technique has the potential to extract meaningful low-dimensional representations in cancer somatic genetic data.
arXiv Detail & Related papers (2020-11-22T17:31:23Z) - Machine Learning Against Cancer: Accurate Diagnosis of Cancer by Machine
Learning Classification of the Whole Genome Sequencing Data [0.0]
We have developed novel methods of MLAC (Machine Learning Against Cancer) achieving perfect results with perfect precision, sensitivity, and specificity.
We have used the whole genome sequencing data acquired by next-generation RNA sequencing techniques in The Cancer Genome Atlas and Genotype-Tissue Expression projects for cancerous and healthy tissues respectively.
arXiv Detail & Related papers (2020-09-12T18:51:47Z) - Select-ProtoNet: Learning to Select for Few-Shot Disease Subtype
Prediction [55.94378672172967]
We focus on few-shot disease subtype prediction problem, identifying subgroups of similar patients.
We introduce meta learning techniques to develop a new model, which can extract the common experience or knowledge from interrelated clinical tasks.
Our new model is built upon a carefully designed meta-learner, called Prototypical Network, that is a simple yet effective meta learning machine for few-shot image classification.
arXiv Detail & Related papers (2020-09-02T02:50:30Z) - A Systematic Approach to Featurization for Cancer Drug Sensitivity
Predictions with Deep Learning [49.86828302591469]
We train >35,000 neural network models, sweeping over common featurization techniques.
We found the RNA-seq to be highly redundant and informative even with subsets larger than 128 features.
arXiv Detail & Related papers (2020-04-30T20:42:17Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.